课题基金 / 基金详情

项目摘要

项目成果

Adam Jay Matzger的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The role of solid-state form in determining the properties of Pharmaceuticals is a critical issue in drug delivery. The ability of a solid to exist as more than one polymorph, supramolecular isomers that differ only in packing and not constitution, creates a situation where each crystal form may have different bioavailability and stability. Only by discovering the presence of new polymorphs and their unique properties can the most efficacious form for a solid dosage be found. This proposal outlines a method for studying and controlling this important aspect of crystal growth. Specific Aim 1-Develop a general methodology for producing new polymorphs. We will create libraries of polymers that can heteronucleate crystallization of solids. It is proposed that varying the functional groups on the surface of the polymer and the orientation and density of these functional groups will allow kinetic access to new polymorphs by creating novel heteronucleation events. Specific Aim 2-lnvestigate the relationship between polymer structure and crystal polymorph obtained. Though it has been established that the majority of crystallizations on a macroscopic scale proceed through heteronucleation events, there is little information about the influence of the substrate on crystallization events. Using the approach developed in Specific Aim 1 to find polymers that create novel polymorphs, we will determine which characteristics are important for controlling polymorph production. Specific Aim 3-Determine the properties of novel polymorphs. With the ultimate goal of finding more efficacious forms of existing and new Pharmaceuticals, the determination of several key properties of the new polymorphs will be undertaken including stability, equilibrium solubility and dissolution rate. brief description of public health relevance: The effectiveness of a drug substance is not solely related to its chemical composition but also to how the molecules arrange in the solid. This proposal offers a method for optimizing this important aspect of drug delivery and will lead to the development of more effective forms of current and future therapeutic agents.
期刊论文(13)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1021/op400102e
发表时间: 2013-07-19
期刊: Organic process research & development
影响因子: 3.4
作者: [Roy S, Chamberlin B, Matzger AJ]
通讯作者: Matzger AJ
DOI: 10.1021/ja302601f
发表时间: 2012-06-20
期刊: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
影响因子: 15
作者: [Lopez-Mejias, Vilmali, Kampf, Jeff W., Matzger, Adam J.]
通讯作者: Matzger, Adam J.
Crystal polymorphism in a carbamazepine derivative: oxcarbazepine.
卡马西平衍生物的晶体多态性:奥卡西平。
DOI: 10.1002/jps.21873
发表时间: 2010
期刊: Journal of pharmaceutical sciences
影响因子: 3.8
作者: [Lutker,KatieM, Matzger,AdamJ]
通讯作者: Matzger,AdamJ
DOI: 10.1002/anie.200903285
发表时间: 2009
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Roy, Saikat, Matzger, Adam J.]
通讯作者: Matzger, Adam J.
7
    Improving drug bioavailability through solid form discovery
    Improving drug bioavailability through solid form discovery
    Improving drug bioavailability through solid form discovery
    Polymer-Based Approaches for Exploring Polymorph Space
    海外基金